China has such a dominant position in active pharmaceutical ingredient (API) production that there is a risk it could "weaponise" access, according to a new congressional report. The document, from ...

(MENAFN- GlobeNewsWire - Nasdaq) The U.S. Active Pharmaceutical Ingredients (API) market is set to expand from $67.11 billion in 2024 to $117.86 billion by 2033, growing at a 6.46% CAGR. This ...

Health experts and pharmaceutical industry leaders yesterday called for policy support and the removal of tariff and non-tariff barriers to boost local production of raw materials for drugs, aiming to ...

Dublin, Nov. 12, 2025 (GLOBE NEWSWIRE) -- The "U.S. Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report by Type of Synthesis (Biotech, Synthetic), by Type of Manufacturer ...

WASHINGTON — Major food, agricultural and consumer products trade groups and companies have given their support to Americans for Ingredient Transparency (AFIT), a new policy advocacy coalition seeking ...

FIRST ON FOX: A new conservative group working to untangle state laws concerning food and personal care ingredients by setting a national standard for ingredient transparency officially launched ...

The Sterile Dry Powder API Market is witnessing robust growth driven by the increasing adoption of injectable drugs, expansion of biologics manufacturing, and the rising prevalence of chronic diseases ...

The traditional APIs segment accounted for the largest share in 2024, whereas the HPAPI segment is expected to grow at the fastest CAGR over the forecast period. The HPAPI segment is further segmented ...

Even when a drug finishes its production in the U.S., its active and inactive components often come from overseas. While pharmaceutical companies have been unveiling plans for new U.S. manufacturing ...